CreativeOne Wealth LLC grew its stake in MetLife, Inc. (NYSE:MET – Free Report) by 27.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,959 shares of the financial services provider’s stock after buying an additional 1,938 shares during the period. CreativeOne Wealth LLC’s holdings in MetLife were worth $739,000 as of its most recent SEC filing.
Other large investors also recently made changes to their positions in the company. MeadowBrook Investment Advisors LLC lifted its holdings in MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. raised its position in shares of MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC lifted its stake in shares of MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after buying an additional 277 shares during the last quarter. Peterson Financial Group Inc. bought a new stake in shares of MetLife during the 3rd quarter worth $30,000. Finally, Fortitude Family Office LLC grew its stake in MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after buying an additional 266 shares during the last quarter. Institutional investors own 89.81% of the company’s stock.
MetLife Stock Down 0.0 %
NYSE MET opened at $88.23 on Friday. MetLife, Inc. has a 1-year low of $63.02 and a 1-year high of $89.05. The company has a market capitalization of $61.09 billion, a price-to-earnings ratio of 17.79, a PEG ratio of 0.81 and a beta of 1.05. The stock’s 50 day moving average is $83.34 and its two-hundred day moving average is $76.59. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Dividend Announcement
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on MET shares. TD Cowen upped their price target on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday. Jefferies Financial Group increased their target price on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 27th. Barclays dropped their price target on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Thursday, October 31st. Morgan Stanley reduced their price objective on MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a research report on Monday, August 19th. Finally, StockNews.com raised shares of MetLife from a “hold” rating to a “buy” rating in a research report on Monday, November 25th. Fourteen analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $88.62.
Get Our Latest Research Report on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- The 3 Best Fintech Stocks to Buy Now
- ServiceNow: Will the High-Flyer Finally Split in 2024?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- MarketBeat Week in Review – 11/25 – 11/29
- How to Invest in the FAANG Stocks
- These 3 Stocks Are Heavy Hitters in Alternative Asset Management
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.